Immunocytochemistry staining protocol for human iPSC-derived oligodendrocyte-like cells

Immunocytochemistry staining protocol for human iPSC-derived oligodendrocyte-like cells

Protocol overview

Pictorial workflow of the steps involved in the ioOligodendrocyte-like cells ICC analysis.

Introduction

Immunocytochemistry (ICC) staining is a powerful technique that uses antibodies for the specific detection and visualisation of proteins or other molecules in a cellular context. As such, ICC staining can provide insights into the distribution, localisation, and abundance of target molecules.

For characterising oligodendroglial cells, scientists rely on cellular markers such as O4 and myelin basic protein (MBP). The O4 antibody recognizes a lipid sulfatide, a common surface marker for oligodendroglial lineage cells. O4 is expressed from a late progenitor stage (late oligodendrocyte progenitor cells) towards a pre-myelinating oligodendrocyte stage. MBP is a myelin-associated protein and its expression is characteristic of pre-myelinating and myelinating oligodendrocytes.

ioOligodendrocyte-like cells express oligodendroglial-specific markers as demonstrated by ICC staining. These cells are positive for O4 on day 1 post-thaw and rapidly mature towards O4 and MBP expression by day 8.

See the ICC data on the product page >

While ICC staining of iPSC-derived cells is a technique done routinely, it does require careful consideration of antibody pairings, cell culture handling instructions, and optimisation to reduce non-specific signals. Here, we provide a step-by-step protocol for the ICC staining of ioOligodendrocyte-like cells used at bit.bio.

Alert: The following protocol recommends general guidelines.

Alert: The following protocol recommends general guidelines.

Materials and equipment

Protocol

This protocol is split into 4 sections:

1: Cell fixation

2: Blocking and permeabilization

3: Primary antibody labelling

4: Secondary antibody labelling


1. Cell fixation

1.1. Prepare fixation solution (4% paraformaldehyde/DPBS) as described in Appendix 1.

Alert: Paraformaldehyde is toxic by ingestion, inhalation, and absorption.

1.2. Slowly remove the culture medium without disturbing the cells.

Alert: ioOligodendrocyte-like cells are sensitive to mechanical shear stress.

Alert: Do not allow the cell layer to dry out.

Alert: Always use micropipettes, not serological pipettes, to prevent cell detachment.

1.3. Carefully add 200 µL of DPBS by pipetting down the side of the wells.

1.4. Gently remove the DPBS without disturbing the cells.

1.5. Carefully add 200 µL of room temperature fixation solution. 

1.6. Incubate for 10 minutes at room temperature.

1.7. Gently remove the fixation solution without disturbing the cells.

1.8. Carefully add 200 μL of DPBS to each well.

1.9. Gently remove the DPBS without disturbing the cells.

1.10. Add 500 μL of DPBS per well, wrap the plate with parafilm and store at 4°C overnight or until staining. Staining should be done ideally within 14 days of fixation.

2. Permeabilization and blocking

2.1. Prepare the following reagents as described in Appendix 1: 

2.1.1 Permeabilization solution (0.02% Saponin in DPBS).

2.1.2. Blocking solution (10% Normal Goat Serum in DBPS).

2.2. Gently remove the DPBS without disturbing the cells.

2.3. Carefully add 200 µL of permeabilization solution to each well.

2.4. Incubate for 15 minutes at room temperature.

2.5. Gently remove the permeabilization solution without disturbing the cells.

2.6. Carefully add 200 µL of blocking solution to each well.

2.7. Incubate for 30 minutes at room temperature.

3. Primary antibody labelling

3.1. Select one test well and one control well from each of your conditions and timepoints.

3.2. Prepare the primary buffer (0.02% saponin / 2% normal goat serum in DPBS) and primary antibody mixture (0.02% saponin / 2% normal goat serum in DPBS + primary antibodies) described in Appendix 1.

3.3. Following the incubation (described in step 2.7), gently remove the blocking solution using a micropipette.

3.4. Carefully add 200 μL of primary antibody mixture by pipetting down the side of the test wells.

3.5. Carefully add 200 μL primary buffer to the control wells.

3.6. Seal plates with parafilm and incubate overnight at 4°C.

3.7. Following the incubation, gently remove the solution without disturbing the cells.

3.8. Carefully add 250 μL of DPBS to each well.

3.9. Incubate for 5 minutes at room temperature.

3.10. Repeat steps 3.7 to 3.9 a further 2 times, for a total of 3 wash steps, leaving the cells in 250 μL of DPBS before moving on to secondary antibody labelling.

4. Secondary antibody labelling

4.1. Prepare the secondary antibody mixture (1% normal goat serum in DPBS + DAPI + secondary antibodies) described in Appendix 1.

4.2. Gently remove the DPBS without disturbing the cells.

4.3. Carefully add 200 μL of secondary antibody mixture by pipetting down the side of the wells.

4.4. Incubate for 1 hour at room temperature.

Alert: Protect the plate from light to prevent fluorophore bleaching; cover plates with tin foil.

4.5. Following the incubation, gently remove the solution from each well without disturbing the cells.

4.6. Carefully add 250 μL of DPBS to each well.

4.7. Incubate cells for 5 minutes at room temperature in the dark.

4.8. Repeat steps 4.5 to 4.7 a further 3 times, for a total of 4 wash steps, leaving the cells in 500 μL of DPBS.

4.9. Image each well using a fluorescent microscope with the fluorescent channel most appropriate for each antibody.

Appendix 1 - Antibody preparation

Fixation solution (4% paraformaldehyde/DPBS):

Alert: Any handling of paraformaldehyde should be performed in an appropriate safety cabinet.

1. Add 30 mL DPBS to a 50 mL centrifuge tube.

2. Add 10 mL of 16% paraformaldehyde.

3. Allow the fixation solution to warm to room temperature before use.

Permeabilization solution (0.02% saponin in DPBS):

1. To prepare a 5% saponin solution in DPBS:

1.1. Weigh 1 g of saponin powder into a 50 mL falcon tube.

1.2. Add 20 mL DPBS.

1.3. Vortex vigorously to fully dissolve the saponin.

2. To prepare permeabilization solution (0.02% saponin in DPBS):

2.1 Add 80 μL of 5% saponin solution to 20 mL of fresh DPBS and vortex vigorously.

Blocking solution (10% normal goat serum in DBPS):

1. Mix 500 μL goat serum with 4.5 mL DPBS.

Primary buffer (0.02% saponin / 2% normal goat serum in DPBS):

1. Mix 10 μL of goat serum with 472.5 μL of permeabilization solution (0.02% saponin in DPBS).

Primary antibody mixture (0.02% saponin / 2% normal goat serum in DPBS + primary antibodies):

1. Centrifuge the stock primary antibody tubes for 5 seconds using a mini centrifuge.

2. Dilute antibodies in the primary buffer according to the recommended dilution described in appendix 2.

Secondary antibody mixture (1% normal goat serum in DPBS + DAPI + secondary antibodies):

1. Add 10 μL goat serum to 1 mL DPBS.

2. Add 2 μL of DAPI (1 mg/mL stock concentration, for a final 2 μg/mL concentration) to the final 1 mL solution.

3. Centrifuge the stock secondary antibody tubes for 5 seconds using a mini centrifuge.

4. Dilute secondary antibodies according to the recommended dilution described in appendix 2.

Appendix 2 - List of antibodies

Table 1: Validated antibody information for the general characterisation of ioOligodendrocyte-like cells.

Primary antibody

Supplier

Cat no

Storage

Species

Dilution

Human/Mouse/Rat/Chicken Oligodendrocyte Marker O4 Antibody

R&D Systems

MAB1326

-20°C

Mouse

1/40

Anti-Myelin Basic Protein Antibody, a.a. 82-87

Merck Millipore

MAB386

-20°C

Rat

1/100

Secondary antibody

Supplier

Cat no

Storage

Species

Dilution

Donkey anti-Mouse IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor 488

Thermo Fisher

A-21202

2°C to 8°C

Donkey

1/500

Donkey Anti-Rat IgG H&L (Alexa Fluor 647)

Abcam

ab150155

2°C to 8°C

Donkey

1/500

DAPI

Bio-Techne

5748/10

-20°C

-

1/500

 

Get started by downloading the user manual for the ioOligodendrocyte-like cells >

Technical support

If you have any questions or need assistance, please reach out to technical@bit.bio and we will do our best to support you.

Published February 2024, version 1.

Related pages

Discover ioCells Learn about our range of human iPSC-derived cells for research and drug discovery
Resources Explore our latest scientific insights, webinars, blogs and videos
Our platform Discover the cell identity coding platform behind our cells